Treatment Switch for Hep B Patients With Renal, Bone Risk Treatment Switch for Hep B Patients With Renal, Bone Risk

A change to a different form of tenofovir might lower the risk for adverse bone and renal effects, new research shows, but concerns about other risks are emerging.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news